Prognostic and therapeutic implications of fibroblast growth factor receptors (FGFRs) 1 and 2 gene amplifications in patients (pts) with advanced breast cancer (ABC).

Authors

null

Fabricio Eugenio Racca

Medical Oncology Department, Breast Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain

Fabricio Eugenio Racca , Ester Zamora , Eva Muñoz-Couselo , Paolo Nuciforo , Meritxell Bellet , Vicente Peg , Cristina Saura , Ana Vivancos , Roberta Fasani , Mafalda Oliveira , Isabel T Rubio , Marta Vilaro , Patricia Gomez , Ludmila Prudkin , Maria Vidal , Jesus Soberino , Alba Meire , Vanesa Ortega , Javier Cortes , Jose Manuel Perez-Garcia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—HER2/ER

Track

Breast Cancer

Sub Track

ER+

Citation

J Clin Oncol 34, 2016 (suppl; abstr 537)

DOI

10.1200/JCO.2016.34.15_suppl.537

Abstract #

537

Poster Bd #

25

Abstract Disclosures